{'output': [['Shire', 'ORG', 'Create', 'Two Distinct Business Units', 'ORG'], ['Shire', 'ORG', 'Considering', 'Spin Off', 'ORG'], ['Hyperactivity Drugs', 'PRODUCT', 'Relate_To', 'Spin Off', 'ORG'], ['Shire', 'ORG', 'Operate_In', 'Pharmaceutical Group', 'ORG'], ['Shire', 'ORG', 'Acquire', 'Baxalta', 'ORG'], ['Shire', 'ORG', 'Decrease', '$20 Billion', 'ECON_INDICATOR'], ['Shire', 'ORG', 'Ambition', 'Achieving', 'ECON_INDICATOR'], ['Shire', 'ORG', 'Forecast', '2020', 'DATE'], ['Shire', 'ORG', 'Make', 'Attention Deficit Hyperactivity Disorder (ADHD)', 'CONCEPT'], ['Shire', 'ORG', 'Make', 'Vyvanse', 'PRODUCT'], ['Analysts', 'PERSON', 'Say', 'Could Be Worth', 'ECON_INDICATOR'], ['Hyperactivity Drugs', 'PRODUCT', 'Standalone Group', 'ORG'], ['Hyperactivity Drugs', 'PRODUCT', 'Relate_To', 'Spin Off', 'ORG'], ['Hyperactivity Drugs', 'PRODUCT', 'Relate_To', 'Standalone Group', 'ORG'], ['Hyperactivity Drugs', 'PRODUCT', 'Relate_To', 'Worth', 'ECON_INDICATOR'], ['Hyperactivity Drugs', 'PRODUCT', 'Relate_To', 'As Much As', 'ECON_INDICATOR'], ['Paul Sandle', 'PERSON', 'Reporting', 'London', 'GPE'], ['Paul Sandle', 'PERSON', 'Reporting', 'Listed Pharmaceutical Group', 'ORG'], ['Kate Holton', 'PERSON', 'Editing', 'London', 'GPE'], ['Kate Holton', 'PERSON', 'Editing', 'Listed Pharmaceutical Group', 'ORG']]}